Keywords: avanir, revenues, fall, fiscal, first, quarter, usa
Avanir's revenues fall in fiscal first quarter
Article | 24 February 2003
The USA's Avanir Pharmaceuticals has posted revenues of $819,000 for thefirst quarter of fiscal 2003 ended December 31, 2002, compared with $5 million during the ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Elan makes "transformational" acquisitions and a divestment
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- SciClone gains China rights to Zensun's Neucardin
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
